Luc Mouthon
#121,050
Most Influential Person Now
Researcher
Luc Mouthon's AcademicInfluence.com Rankings
Luc Mouthoncomputer-science Degrees
Computer Science
#4895
World Rank
#5167
Historical Rank
Data Science
#71
World Rank
#73
Historical Rank
Computational Linguistics
#564
World Rank
#574
Historical Rank
Machine Learning
#1106
World Rank
#1124
Historical Rank

Luc Mouthonmathematics Degrees
Mathematics
#5869
World Rank
#8221
Historical Rank
Measure Theory
#991
World Rank
#1285
Historical Rank

Download Badge
Computer Science Mathematics
Luc Mouthon's Degrees
- PhD Computer Science Université Paris Cité
- Masters Computer Science Université Paris Cité
- Bachelors Mathematics Université Paris Cité
Similar Degrees You Can Earn
Why Is Luc Mouthon Influential?
(Suggest an Edit or Addition)Luc Mouthon's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients (2020) (1962)
- Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. (2014) (801)
- Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. (2005) (738)
- The Five-Factor Score Revisited: Assessment of Prognoses of Systemic Necrotizing Vasculitides Based on the French Vasculitis Study Group (FVSG) Cohort (2011) (679)
- Inflammation, growth factors, and pulmonary vascular remodeling. (2009) (663)
- Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. (2013) (622)
- Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. (2008) (582)
- Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19 (2020) (537)
- Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. (2010) (431)
- Antineutrophil Cytoplasmic Antibodies and the ChurgStrauss Syndrome (2005) (375)
- Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data (2020) (367)
- Self-reactive antibodies (natural autoantibodies) in healthy individuals. (1998) (343)
- Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. (2015) (339)
- Common Variable Immunodeficiency Patient Classification Based on Impaired B Cell Memory Differentiation Correlates with Clinical Aspects (2003) (329)
- Mapping and predicting mortality from systemic sclerosis (2017) (328)
- Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. (2005) (319)
- Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. (2003) (311)
- Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. (2008) (292)
- Vasculitides associated with malignancies: analysis of sixty patients. (2007) (275)
- Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action (2007) (257)
- Churg-Strauss syndrome with poor-prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients. (2007) (243)
- Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients (2020) (241)
- High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. (2008) (228)
- Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. (2003) (225)
- Deaths Occurring During the First Year After Treatment Onset for Polyarteritis Nodosa, Microscopic Polyangiitis, and Churg-Strauss Syndrome: A Retrospective Analysis of Causes and Factors Predictive of Mortality Based on 595 Patients (2005) (222)
- Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. (2011) (220)
- Pathogenesis of hemophagocytic syndrome (HPS). (2004) (215)
- Genome-Wide Scan Identifies TNIP1, PSORS1C1, and RHOB as Novel Risk Loci for Systemic Sclerosis (2011) (210)
- Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients (2007) (209)
- Mechanisms of action of intravenous immune globulin in immune‐mediated diseases (1996) (204)
- Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. (2008) (204)
- Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial (2021) (195)
- Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2) (2018) (192)
- Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. (2009) (192)
- Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey. (2007) (191)
- Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus (2001) (189)
- No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial (2020) (188)
- The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. (2009) (187)
- Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies (2017) (187)
- Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies (2022) (185)
- Geoepidemiology of systemic sclerosis. (2010) (181)
- Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study (2008) (179)
- Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. (1995) (177)
- Brief Communication: Case Reports of Ribavirin Treatment for Chronic Hepatitis E (2010) (177)
- Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients. (2008) (171)
- Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials. (2013) (169)
- Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the Mouse1 (2009) (169)
- Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis. (2012) (168)
- Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension (2005) (167)
- Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. (2011) (166)
- Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. (2006) (166)
- Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome. (2012) (161)
- Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody. (2012) (161)
- Systemic sclerosis-associated pulmonary arterial hypertension. (2010) (156)
- STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. (2009) (156)
- New insights into the pathogenesis of systemic sclerosis. (2003) (155)
- Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls. (2012) (155)
- Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA). (2016) (154)
- Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients. (2004) (153)
- Prevalence of systemic sclerosis in a French multi-ethnic county. (2004) (150)
- Renal complications and scleroderma renal crisis. (2006) (144)
- Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients (2008) (143)
- Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival (2010) (142)
- European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes (2017) (141)
- Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome). (2014) (138)
- Analysis of the normal human IgG antibody repertoire. Evidence that IgG autoantibodies of healthy adults recognize a limited and conserved set of protein antigens in homologous tissues. (1995) (137)
- Treatment of Systemic Necrotizing Vasculitides in Patients Aged Sixty‐Five Years or Older: Results of a Multicenter, Open‐Label, Randomized Controlled Trial of Corticosteroid and Cyclophosphamide–Based Induction Therapy (2015) (137)
- Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. (2007) (136)
- Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis (2009) (135)
- Intravenous immunoglobulins for steroid‐refractory esophageal involvement related to polymyositis and dermatomyositis: A series of 73 patients (2010) (132)
- Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension (2006) (131)
- Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? (2013) (131)
- Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study. (2008) (130)
- Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era (2012) (130)
- Clinical applications of intravenous immunoglobulins (IVIg) – beyond immunodeficiencies and neurology (2009) (125)
- Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. (2013) (123)
- Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population (2010) (122)
- Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study (2015) (122)
- Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. (2007) (121)
- Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension. (2012) (121)
- Autoimmune manifestations in primary immune deficiencies. (2009) (121)
- Pathogenesis of giant cell arteritis: More than just an inflammatory condition? (2010) (118)
- The Clinical Spectrum and Therapeutic Management of Hypocomplementemic Urticarial Vasculitis: Data From a French Nationwide Study of Fifty‐Seven Patients (2015) (117)
- Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome. (2017) (116)
- Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides (2018) (116)
- Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-alpha present in serum from patients with systemic lupus erythematosus. (2003) (114)
- Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scale (2007) (114)
- Interstitial Lung Disease in Anti–Jo‐1 Patients With Antisynthetase Syndrome (2013) (114)
- BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. (2009) (113)
- Long‐Term Outcomes Among Participants in the WEGENT Trial of Remission‐Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis (2016) (111)
- Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension. (2008) (111)
- Analysis of the natural human IgG antibody repertoire: life‐long stability of reactivities towards self antigens contrasts with age‐dependent diversification of reactivities against bacterial antigens (1995) (111)
- The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis. (2008) (110)
- Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome. (2015) (108)
- Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia. (2002) (107)
- Microscopic polyangiitis and polyarteritis nodosa: how and when do they start? (2003) (106)
- The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context (2013) (101)
- Adding Azathioprine to Remission‐Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors (2017) (100)
- Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP) (2006) (100)
- The Role of Inflammation and Autoimmunity in the Pathophysiology of Pulmonary Arterial Hypertension (2013) (98)
- Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers (2011) (97)
- Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS) (2017) (97)
- Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis (2007) (97)
- The Self‐Reactive Antibody Repertoire of Normal Human Serum IgM is Acquired in Early Childhood and Remains Conserved Throughout Life (1996) (96)
- Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature (2019) (95)
- Scleroderma Renal Crisis: A Rare but Severe Complication of Systemic Sclerosis (2011) (92)
- Systemic sclerosis: state of the art on clinical practice guidelines (2018) (91)
- Severe Perturbations of the Blood T Cell Repertoire in Polymyositis, But Not Dermatomyositis Patients1 (2001) (90)
- Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma (2011) (90)
- Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients. (2017) (88)
- Long‐term outcome of patients with polymyositis/ dermatomyositis and anti‐PM‐Scl antibody (2010) (86)
- Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes. (2015) (86)
- Granulomatosis-associated common variable immunodeficiency disorder: a case–control study versus sarcoidosis (2012) (86)
- Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients. (2011) (85)
- Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis (2012) (85)
- Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease. (2011) (85)
- NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis (2010) (85)
- A descriptive and prognostic study of systemic sclerosis-associated myopathies (2008) (84)
- Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis. (2015) (81)
- Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides. (2013) (77)
- [Interstitial lung disease in systemic sclerosis]. (2007) (77)
- Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. (2003) (76)
- Sjogren's syndrome is associated with and not secondary to systemic sclerosis. (2006) (76)
- Anti‐IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss): Data on Seventeen Patients (2016) (76)
- Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers (2021) (76)
- Is pulmonary arterial hypertension really a late complication of systemic sclerosis? (2009) (75)
- Mechanisms of action of intravenous immunoglobulin. (2017) (75)
- Systemic Sclerosis‐Associated Myopathy (2007) (75)
- The telomere/telomerase system in autoimmune and systemic immune-mediated diseases. (2010) (74)
- Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ) (2005) (74)
- Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors. (2014) (73)
- Mood and anxiety disorders in systemic sclerosis patients. (2011) (73)
- Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia. (2005) (72)
- Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2. (2002) (70)
- Tumor necrosis factor-alpha blockade and the risk of vasculitis. (2004) (70)
- Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis (2020) (68)
- Severe respiratory syncytial virus pneumonia after autologous bone marrow transplantation: a report of three cases and review. (1992) (68)
- TNF alpha antagonist therapy and safety monitoring. (2011) (68)
- Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide (2007) (68)
- Pregnancies in systemic necrotizing vasculitides: report on 12 women and their 20 pregnancies. (2011) (68)
- Recommendations for the care of oral involvement in patients with systemic sclerosis (2011) (68)
- Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients. (2014) (67)
- Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease (2006) (66)
- Therapy of polymyositis and dermatomyositis. (2011) (66)
- Stability of Natural Self-Reactive Antibody Repertoires During Aging (2004) (66)
- Myopathies related to systemic sclerosis: a case–control study of associated clinical and immunological features (2010) (65)
- Phenotype-Haplotype Correlation of IRF5 in Systemic Sclerosis: Role of 2 Haplotypes in Disease Severity (2010) (64)
- Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies. (2011) (64)
- Antiendothelial Cells Autoantibodies in Vasculitis-Associated Systemic Diseases (2008) (64)
- Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome. (2010) (63)
- Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis. (2007) (63)
- Analysis of human self-reactive antibody repertoires by quantitative immunoblotting. (2000) (63)
- Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature. (2017) (62)
- Ischemic Digital Ulcers Affect Hand Disability and Pain in Systemic Sclerosis (2014) (61)
- Pulmonary arterial hypertension: an autoimmune disease? (2005) (61)
- Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity. (2012) (61)
- Bevacizumab-induced cardiovascular events: a consequence of cholesterol emboli syndrome? (2007) (61)
- Impact of cardiac magnetic resonance imaging for assessment of Churg-Strauss syndrome: a cross-sectional study in 20 patients. (2009) (60)
- Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis (2019) (59)
- Scleroderma Renal Crisis (2014) (59)
- Proteinase 3, the Autoantigen in Granulomatosis with Polyangiitis, Associates with Calreticulin on Apoptotic Neutrophils, Impairs Macrophage Phagocytosis, and Promotes Inflammation (2012) (59)
- Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: A French Nationwide Study of Ninety‐Two Patients (2015) (59)
- Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis. (2011) (59)
- Pathophysiology of systemic sclerosis: state of the art in 2014. (2014) (58)
- A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis. (2017) (58)
- Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension. (2006) (57)
- Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study. (2011) (56)
- Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis (2016) (56)
- Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients. (2013) (55)
- Patient preference disability questionnaire in systemic sclerosis: a cross-sectional survey. (2008) (55)
- Endothelin-1 expression in scleroderma renal crisis. (2011) (54)
- Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach (2011) (53)
- Independent replication establishes the CD247 gene as a genetic systemic sclerosis susceptibility factor (2011) (53)
- Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach. (2007) (53)
- IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients. (2004) (53)
- Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry (2018) (53)
- Rituximab (MabThera) therapy and safety management. Clinical tool guide. (2008) (53)
- Antifibroblast antibodies from systemic sclerosis patients bind to α-enolase and are associated with interstitial lung disease (2009) (53)
- Implication of B lymphocytes in the pathogenesis of ANCA-associated vasculitides. (2015) (52)
- Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype. (2011) (52)
- Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegener's granulomatosis (2010) (52)
- Intravenous Immunoglobulin Expands Regulatory T Cells in Autoimmune Rheumatic Disease (2012) (51)
- Altered control of self-reactive IgG by autologous IgM in patients with warm autoimmune hemolytic anemia. (2000) (51)
- C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: results from a large french cohort and meta-analysis. (2011) (51)
- Polyarteritis Nodosa and Churg-Strauss Angiitis: Characteristics and Outcome in 38 Patients over 65 Years (2002) (51)
- Personalized Physical Therapy Versus Usual Care for Patients With Systemic Sclerosis: A Randomized Controlled Trial (2017) (51)
- Scleroderma Peripheral B Lymphocytes Secrete Interleukin‐6 and Transforming Growth Factor β and Activate Fibroblasts (2017) (51)
- Systemic Vasculitis During the Course of Systemic Sclerosis (2013) (50)
- Treatment strategies and outcome of induction-refractory Wegener's granulomatosis or microscopic polyangiitis: analysis of 32 patients with first-line induction-refractory disease in the WEGENT trial (2010) (50)
- Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts. (2015) (50)
- Impact of pain in health related quality of life of patients with systemic sclerosis. (2006) (50)
- Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension (2018) (50)
- Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population. (2010) (49)
- New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN). (2012) (48)
- Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients (2016) (48)
- Association of Gender with Clinical Expression, Quality of Life, Disability, and Depression and Anxiety in Patients with Systemic Sclerosis (2011) (48)
- Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4. (2010) (48)
- In vitro and in vivo properties differ among liquid intravenous immunoglobulin preparations (2013) (47)
- Outcomes in critically ill patients with systemic rheumatic disease: a multicenter study. (2015) (47)
- Kinetic Profiles and Management of Hepatitis B Virus Reactivation in Patients With Immune‐Mediated Inflammatory Diseases (2013) (46)
- Acquired C1-Inhibitor Deficiency: 7 Patients Treated with Rituximab (2012) (46)
- Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group. (2014) (46)
- Immunoglobulins and the regulation of autoimmunity through the immune network. (1996) (45)
- Brief Report: Childhood‐Onset Systemic Necrotizing Vasculitides: Long‐Term Data From the French Vasculitis Study Group Registry (2015) (45)
- Identification of target antigens of antiendothelial cell antibodies in healthy individuals: A proteomic approach (2008) (45)
- Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study (2017) (44)
- Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. (2012) (44)
- Clinical, Functional and Health-Related Quality of Life Correlates of Clinically Significant Symptoms of Anxiety and Depression in Patients with Systemic Sclerosis: A Cross-Sectional Survey (2014) (44)
- Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study (2018) (44)
- Interstitial lung disease in systemic sclerosis. (2011) (43)
- Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors. (2014) (43)
- IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction (2011) (43)
- Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B). (2006) (43)
- A Mimic of p21WAF1/CIP1 Ameliorates Murine Lupus1 (2005) (43)
- Natural anti-endothelial cell antibodies. (2008) (42)
- Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population (2006) (41)
- Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (2017) (41)
- Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases. (1994) (41)
- European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis (2017) (41)
- Sarcoidosis Occurring After Lymphoma (2014) (41)
- Alveolar haemorrhage in ANCA-associated vasculitides: 80 patients' features and prognostic factors. (2012) (41)
- Relevance of diagnostic investigations in patients with uveitis: Retrospective cohort study on 300 patients. (2017) (40)
- Intravenous Immunoglobulins in Autoimmune and Inflammatory Diseases (2007) (40)
- Pulmonary veno-occlusive disease: the bête noire of pulmonary hypertension in connective tissue diseases? (2011) (40)
- [Interstitial lung disease in connective tissue disorders]. (2005) (40)
- Childhood- versus adult-onset ANCA-associated vasculitides: A nested, matched case-control study from the French Vasculitis Study Group Registry. (2017) (40)
- Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases. (2013) (39)
- Natural and disease associated anti-myeloperoxidase (MPO) autoantibodies. (2008) (37)
- Independent Replication and Metaanalysis of Association Studies Establish TNFSF4 as a Susceptibility Gene Preferentially Associated with the Subset of Anticentromere-positive Patients with Systemic Sclerosis (2012) (37)
- Antiphospholipid syndrome: state of the art on clinical practice guidelines (2018) (37)
- The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis (2010) (37)
- Patients’ views and needs about systemic sclerosis and its management: a qualitative interview study (2017) (37)
- The Scleroderma Kidney: Progress in Risk Factors, Therapy, and Prevention (2011) (36)
- Risk of scleroderma according to the type of immune checkpoint inhibitors. (2020) (36)
- Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndrome. (1999) (36)
- Intrasinusoidal cytotoxic CD8+ T cells in nodular regenerative hyperplasia of the liver. (2004) (36)
- Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group. (2015) (36)
- Intravenous immunoglobulins in infectious diseases: where do we stand? (2003) (36)
- Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients. (2010) (35)
- Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients (2014) (35)
- [Bosentan for treatment of active digital ulcers in patients with systemic sclerosis]. (2006) (35)
- Employment status and socio-economic burden in systemic sclerosis: a cross-sectional survey. (2010) (35)
- Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factor. (2019) (34)
- The economic burden and health-related quality of life associated with systemic sclerosis in France (2015) (34)
- No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected data to emulate a target trial (2020) (33)
- IgM and IgG autoantibodies from microscopic polyangiitis patients but not those with other small- and medium-sized vessel vasculitides recognize multiple endothelial cell antigens. (2003) (33)
- ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis (2020) (33)
- Granulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experience. (2015) (33)
- The Advantage of Specific Intravenous Immunoglobulin (sIVIG) on Regular IVIG: Experience of the Last Decade (2012) (33)
- Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology (2019) (33)
- Serum Eosinophil Cationic Protein (2007) (32)
- Idiopathic CD 4 Lymphocytopenia Clinical and Immunologic Characteristics and Follow-Up of 40 Patients (2014) (32)
- Basophils and nephritis in lupus. (2010) (32)
- Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients (2022) (32)
- Validation of the Self‐Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient‐Centered Intervention Network Cohort Study (2016) (32)
- The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts (2018) (32)
- Ocular involvement in granulomatosis with polyangiitis: A single-center cohort study on 63 patients. (2019) (32)
- There is a need for new systemic sclerosis subset criteria. A content analytic approach (2018) (32)
- Idiopathic CD4 Lymphocytopenia (2014) (31)
- Identification of target antigens of self‐reactive IgG in intravenous immunoglobulin preparations (2009) (31)
- Sjögren’s syndrome: state of the art on clinical practice guidelines (2018) (31)
- Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients (2019) (31)
- Anti-endothelial cell antibodies in vasculitis: A systematic review. (2017) (31)
- Arterial stiffness predicts severe progression in systemic sclerosis: the ERAMS study (2007) (31)
- Impact of cardiac magnetic resonance imaging on eosinophilic granulomatosis with polyangiitis outcomes: A long-term retrospective study on 42 patients. (2015) (31)
- Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies. (2007) (31)
- Interstitial Lung Disease Associated with Systemic Sclerosis (2007) (31)
- mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G (2018) (30)
- Patients' beliefs about the causes of systemic lupus erythematosus. (2010) (30)
- Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupus. (2017) (30)
- Association of hypoxia‐inducible factor 1A (HIF1A) gene polymorphisms with systemic sclerosis in a French European Caucasian population (2009) (29)
- DUSP4-mediated accelerated T-cell senescence in idiopathic CD4 lymphopenia. (2015) (29)
- Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality. (2019) (28)
- Levamisole-induced vasculopathy: A systematic review. (2019) (28)
- Anti-annexin V antibodies: are they prothrombotic? (2005) (28)
- Proteomes of umbilical vein and microvascular endothelial cells reflect distinct biological properties and influence immune recognition (2012) (28)
- Localized neurological necrotizing vasculitides. Three cases with isolated mononeuritis multiplex. (2001) (28)
- Polyreactive Autoantibodies Purified from Human Intravenous Immunoglobulins Prevent the Development of Experimental Autoimmune Diseases (2003) (28)
- Scleroderma Renal Crisis, Still a Life‐Threatening Complication (2007) (28)
- Clinical and pathological significance of cutaneous manifestations in ANCA-associated vasculitides. (2017) (27)
- Therapeutic options for systemic sclerosis related interstitial lung diseases. (2010) (27)
- Sensitivity to Change in Systemic Sclerosis of the McMaster-Toronto Arthritis Patient Preference Disability Questionnaire (MACTAR): Shift in Patient Priorities Over Time (2010) (27)
- Cardiac magnetic resonance imaging in Churg-Strauss-syndrome. Impact of immunosuppressants on outcome assessed in a prospective study on 8 patients. (2010) (27)
- Pre-test probability for SARS-Cov-2-related infection score: The PARIS score (2020) (27)
- Intravenous Immunoglobulin Therapy for Pure Red Cell Aplasia Related to Human Parvovirus B 19 Infection : A Retrospective Study of 10 Patients and Review of the Literature (2013) (27)
- Molecular analysis of vascular smooth muscle cells from patients with giant cell arteritis: Targeting endothelin-1 receptor to control proliferation. (2017) (26)
- Postrehabilitation Functional Improvements in Patients With Inflammatory Myopathies: The Results of a Randomized Controlled Trial. (2017) (26)
- Identification of target antigens of anti-endothelial cell antibodies in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides: a proteomic approach. (2014) (26)
- Cerebral Vasculopathy Is Associated with Severe Vascular Manifestations in Systemic Sclerosis (2009) (26)
- Concomitant polymyositis and myasthenia gravis reveal malignant thymoma. A case report and review of the literature. (1999) (26)
- Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases (2022) (25)
- The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET (2021) (25)
- Association Study of ITGAM, ITGAX, and CD58 Autoimmune Risk Loci in Systemic Sclerosis: Results from 2 Large European Caucasian Cohorts (2011) (25)
- Analysis of antibody reactivities toward self antigens of IgM of patients with Waldenström's macroglobulinemia. (1997) (25)
- Rituximab versus azathioprine for maintenance in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (MAINRITSAN): Follow-up at 34 months (2013) (25)
- Seroneutralization of Omicron BA.1 and BA.2 in patients receiving anti-SARS-CoV-2 monoclonal antibodies. (2022) (25)
- Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. A prospective study in 117 patients (2013) (25)
- Long-term outcome of 37 patients with Wegener's granulomatosis with renal involvement. (2007) (24)
- Dividing the Janus vasculitis? Pathophysiology of eosinophilic granulomatosis with polyangitis. (2016) (24)
- Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial (2021) (24)
- Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study (2020) (23)
- Hydroxyethyl starch-induced renal insufficiency after plasma exchange in a patient with polymyositis and liver cirrhosis. (2001) (23)
- Proteomic analysis of vascular smooth muscle cells in physiological condition and in pulmonary arterial hypertension: Toward contractile versus synthetic phenotypes (2016) (23)
- Abatacept therapy and safety management. (2012) (23)
- Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial. (2019) (23)
- Undifferentiated connective tissue disease: state of the art on clinical practice guidelines (2019) (23)
- Orientation diagnostique devant une lymphopénie (2006) (22)
- Pulmonary arterial hypertension in idiopathic inflammatory myopathies (2016) (22)
- Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases (2006) (22)
- Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: a case-control study. (2003) (22)
- A Combined SDS‐PAGE and Proteomics Approach to Identify Target Autoantigens in Healthy Individuals and Patients with Autoimmune Diseases (2007) (22)
- Tracheobronchial involvement of relapsing polychondritis. (2019) (22)
- Colchicine: a simple and effective treatment for pericarditis in systemic lupus erythematosus? A report of 10 cases (2015) (21)
- Physical and occupational therapy referral and use among systemic sclerosis patients with impaired hand function: results from a Canadian national survey. (2012) (21)
- Scleroderma Renal Crisis. (2015) (21)
- Neurotrophins are expressed in giant cell arteritis lesions and may contribute to vascular remodeling (2014) (21)
- IgG4-related diseases: state of the art on clinical practice guidelines (2019) (21)
- Systemic small sized vessel vasculitis after massive antigen inhalation. (2001) (21)
- Instability of Natural Antibody Repertoires in Systemic Lupus Erythematosus Patients, Revealed by Multiparametric Analysis of Serum Antibody Reactivities (1997) (21)
- Employment, work disability and quality of life in patients with ANCA-associated vasculitides. The EXPOVAS study. (2016) (21)
- Factors Associated with Major Cardiovascular Events in Patients with Systemic Necrotizing Vasculitides: Results of a Longterm Followup Study (2014) (21)
- Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients. (2018) (21)
- Deep Learning-based Approach for Automated Assessment of Interstitial Lung Disease in Systemic Sclerosis on CT Images. (2020) (21)
- Contribution of antiferritin antibodies to diagnosis of giant cell arteritis (2013) (20)
- [Systemic sclerosis: pathophysiology of a multifaceted disease]. (2006) (20)
- Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life. (2016) (20)
- Proteomic analysis of neutrophils in ANCA-associated vasculitis reveals a dysregulation in proteinase 3-associated proteins such as annexin-A1 involved in apoptotic cell clearance. (2019) (20)
- Selective impairment of serum antibody repertoires toward muscle and thymus antigens in patients with seronegative and seropositive myasthenia gravis (1998) (20)
- Long-term outcome of children with pediatric-onset cutaneous and visceral polyarteritis nodosa. (2015) (20)
- Using Optimal Test Assembly Methods for Shortening Patient‐Reported Outcome Measures: Development and Validation of the Cochin Hand Function Scale‐6: A Scleroderma Patient‐Centered Intervention Network Cohort Study (2016) (19)
- French recommendations for the management of systemic sclerosis (2021) (19)
- Subacute Cutaneous Lupus Erythematosus Induced and Exacerbated by Proton Pump Inhibitors (2013) (19)
- Anti-RNA polymerase III antibodies are associated with scleroderma renal crisis in a French cohort (2011) (19)
- Medical cure of plasma cell granuloma of the thyroid associated with Hashimoto's thyroiditis: a case report and review. (2004) (19)
- Microscopic polyangiitis: Clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry. (2020) (19)
- Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial. (2017) (19)
- Exercise habits and factors associated with exercise in systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study (2018) (19)
- Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients (2020) (18)
- [Immunomodulatory effects of intravenous immunoglobulins]. (2000) (18)
- Patient acceptable symptom state and minimal clinically important difference for patient-reported outcomes in systemic sclerosis: A secondary analysis of a randomized controlled trial comparing personalized physical therapy to usual care. (2019) (18)
- Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis (2020) (18)
- A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension (2015) (18)
- Elastic Registration-driven Deep Learning for Longitudinal Assessment of Systemic Sclerosis Interstitial Lung Disease at CT. (2020) (18)
- Hepatitis B virus-related polyarteritis nodosa and membranous nephropathy. (1995) (18)
- Characteristics of Vogt-Koyanagi-Harada Disease in a French Cohort: Ethnicity, Systemic Manifestations, and HLA Genotype Data (2008) (18)
- Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis (2011) (18)
- Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case–control study with hydroxychloroquine blood-level analysis (2020) (18)
- Successful treatment of thymoma‐associated pure red cell aplasia with intravenous immunoglobulins (2000) (18)
- Pneumococcal and influenza vaccination rates in patients treated with corticosteroids and/or immunosuppressive therapies for systemic autoimmune diseases: A cross-sectional study. (2017) (18)
- Translation, cross-cultural adaptation, and validation of the Mouth Handicap in Systemic Sclerosis questionnaire (MHISS) into the Dutch language (2013) (18)
- Corticosteroid-sparing benefit of intravenous immunoglobulin in systemic sclerosis-associated myopathy: A comparative study in 52 patients. (2019) (18)
- High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance (2017) (17)
- Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases. (1994) (17)
- Cardiac Intravoxel Incoherent Motion Diffusion‐Weighted Magnetic Resonance Imaging With T1 Mapping to Assess Myocardial Perfusion and Fibrosis in Systemic Sclerosis: Association With Cardiac Events From a Prospective Cohort Study (2020) (17)
- Patients', relatives', and practitioners' views of pulmonary arterial hypertension: A qualitative study. (2016) (17)
- Low influenza vaccination rate among patients with systemic sclerosis. (2010) (17)
- Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines (2019) (16)
- IgA glomerulonephritis associated with microscopic polyangiitis or Churg-Strauss syndrome. (1999) (16)
- Mycophenolate mofetil following cyclophosphamide in worsening systemic sclerosis-associated interstitial lung disease (2016) (16)
- Validation of the COVID-19 Fears Questionnaires for Chronic Medical Conditions: A Scleroderma Patient-centered Intervention Network COVID-19 Cohort study (2020) (16)
- Polymorphic markers of the fibrillin-1 gene and systemic sclerosis in European Caucasian patients. (2008) (16)
- Association study of B-cell marker gene polymorphisms in European Caucasian patients with systemic sclerosis. (2011) (16)
- [Pathogenesis of systemic scleroderma: immunological aspects]. (2002) (16)
- Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: A Case–Control Study (2020) (16)
- Altered Responses to Homeostatic Cytokines in Patients with Idiopathic CD4 Lymphocytopenia (2013) (16)
- Outcome of Patients with Systemic Sclerosis in the Intensive Care Unit (2015) (16)
- Granulomatosis with polyangiitis according to geographic origin and ethnicity: clinical-biological presentation and outcome in a French population (2016) (16)
- Systemic sclerosis: Sexual dysfunction and lower urinary tract symptoms in 73 patients. (2016) (16)
- Is there today a place for corticosteroids in the treatment of scleroderma? (2019) (16)
- [Diagnosis of lymphocytopenia]. (2006) (15)
- Treatment of systemic necrotizing vasculitides in patients ≥ 65 years old: Results of the multicenter randomized CORTAGE trial (2013) (15)
- Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study. (2019) (15)
- Analysis of autoantibody repertoires in small- and medium-sized vessels vasculitides. Evidence for specific perturbations in polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and Wegener's granulomatosis. (2005) (15)
- Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss). (2020) (14)
- Changes over Time and Responsiveness of the Cochin Hand Function Scale and Mouth Handicap in Systemic Sclerosis Scale in Patients with Systemic Sclerosis: A Prospective Observational Study (2016) (14)
- Management of secondary immune deficiencies: what is the role of immunoglobulins? (2013) (14)
- Novelties in the field of autoimmunity - 1st Saint Petersburg congress of autoimmunity, the bridge between east and west. (2017) (14)
- Neutrophils and B lymphocytes in ANCA‐associated vasculitis (2009) (13)
- Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies (2022) (13)
- Esophageal involvement as an initial manifestation of Churg-Strauss syndrome. (2007) (13)
- Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database (2020) (13)
- Characteristics, prognosis, and outcomes of cutaneous ischemia and gangrene in systemic necrotizing vasculitides: a retrospective multicenter study. (2014) (13)
- Use of Elastic Registration in Pulmonary MRI for the Assessment of Pulmonary Fibrosis in Patients with Systemic Sclerosis. (2019) (13)
- Severe COVID-19 is associated with hyperactivation of the alternative complement pathway (2021) (13)
- Lymphoma complicating common variable immunodeficiency with granulomatous disease: report of two cases (2003) (13)
- Radiological bone lesions in fibroblastic rheumatism; case report. (2007) (12)
- Analysis of risk factors for complications and adverse obstetrical outcomes in women with Takayasu arteritis: a French retrospective study and literature review (2020) (12)
- Association of Metalloproteinase Gene Polymorphisms with Systemic Sclerosis in the European Caucasian Population (2010) (12)
- [Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis]. (2004) (12)
- The association of sociodemographic and disease variables with hand function: a Scleroderma Patient-centered Intervention Network cohort study. (2018) (12)
- Psychometric validation of the Hand Disability in Systemic Sclerosis-Digital Ulcers (HDISS-DU®) patient-reported outcome instrument (2020) (12)
- [Treatment of systemic autoimmune and inflammatory diseases with rituximab]. (2009) (12)
- Effect of plasma exchange in acute respiratory failure due to Anti-neutrophil cytoplasmic antibody-associated vasculitis (2018) (12)
- Childhood- versus Adult-Onset Polyarteritis Nodosa Results from the French Vasculitis Study Group Registry. (2018) (12)
- Angiotensin-Converting Enzyme Gene Does Not Contribute to Genetic Susceptibility to Systemic Sclerosis in European Caucasians (2009) (12)
- [Lymphocytopenia: aetiology and diagnosis, when to think about idiopathic CD4(+) lymphocytopenia?]. (2012) (12)
- Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registry. (2021) (12)
- Use of bosentan for digital ulcers related to systemic sclerosis: a real-life retrospective French study of 89 patients treated since specific approval (2014) (12)
- Differences in patients with systemic sclerosis recruited from associations and tertiary care settings. (2010) (11)
- IMMUNOMODULATION OF AUTOIMMUNE AND SYSTEMIC INFLAMMATORY DISEASES WITH INTRAVENOUS IMMUNOGLOBULIN (1994) (11)
- Mechanisms of Intravenous Immunoglobulin Action in the Treatment of Autoimmune Disorders (2012) (11)
- Localized subcutaneous Nocardia farcinica abscess in a woman with overlap syndrome between systemic scleroderma and polymyositis. (1999) (11)
- Evolution of previous sarcoidosis under type 1 interferons given for severe associated disease (2005) (11)
- Factors influencing influenza-vaccination in adults under immunosuppressive therapy for a systemic inflammatory disease. (2009) (10)
- Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis. (2007) (10)
- Severe mitral stenosis as the first manifestation of systemic lupus erythematosus in a 20-year-old woman: the value of magnetic resonance imaging in the diagnosis of Libman-Sacks endocarditis (2014) (10)
- Antigen inhalation as a triggering factor in systemic small-sized-vessel vasculitis. Four cases. (2001) (10)
- Treating systemic sclerosis in 2001. (2001) (10)
- Association Study of Serotonin Transporter Gene (SLC6A4) in Systemic Sclerosis in European Caucasian Populations (2010) (10)
- Transgenic Mice Expressing Human Proteinase 3 Exhibit Sustained Neutrophil-Associated Peritonitis (2017) (10)
- OP0213 Rituximab Versus Azathioprine for Maintenance in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis (MAINRITSAN): Follow Up at 34 Months (2013) (10)
- Spectrum and Prognosis of Antineutrophil Cytoplasmic Antibody–associated Vasculitis-related Bronchiectasis: Data from 61 Patients (2019) (10)
- IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts (2008) (10)
- Interferon‐α in corticosteroid‐resistant asthma and Churg–Strauss syndrome (2003) (10)
- Effects of a multi-faceted education and support programme on anxiety symptoms among people with systemic sclerosis and anxiety during COVID-19 (SPIN-CHAT): a two-arm parallel, partially nested, randomised, controlled trial (2021) (10)
- Extra-haematological manifestations related to human parvovirus B19 infection: retrospective study in 25 adults (2018) (10)
- Association study of 3 rheumatoid arthritis risk loci in systemic sclerosis in European Caucasian population. (2011) (10)
- Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group. (2019) (9)
- Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence (2020) (9)
- [Renal involvement in patients with systemic sclerosis]. (2006) (9)
- Persistent Nasal Inflammation 5 Months after Acute Anosmia in Patients with COVID-19 (2021) (9)
- Brachial plexopathy associated with diffuse edematous scleroderma. (2000) (9)
- Clinical characteristics and persistence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in 4,607 French healthcare workers: Comparison with European countries (2020) (9)
- Antitopoisomerase 1 Antibodies in Systemic Sclerosis (2007) (9)
- [Hand involvement in systemic sclerosis]. (2013) (9)
- Patients with systemic inflammatory and autoimmune diseases are at risk of vaccine-preventable illnesses. (2011) (9)
- Polyarteritis nodosa and mixed cryoglobulinaemia related to hepatitis B and C virus coinfection (2001) (9)
- Candidate Gene Study in Systemic Sclerosis Identifies a Rare and Functional Variant of the TNFAIP 3 Locus as a Risk Factor for Polyautoimmunity (2012) (9)
- Testing for levamisole and cocaine in hair samples for the diagnosis of levamisole‐related panniculitis (2015) (9)
- Utilization of intravenous or subcutaneous immunoglobulins in secondary immune deficiency (ULTIMATE): A retrospective multicenter study. (2020) (9)
- Intraabdominal macrocystic lymphatic malformation (lymphangioma) infected with Salmonella enteritidis: case report and review. (1997) (9)
- SSc in 2011: From mechanisms to medicines (2012) (9)
- [Eosinophil granule cationic proteins: eosinophil activation markers]. (2006) (9)
- Osteomalacia revealing celiac disease and primary biliary cirrhosis-related Fanconi syndrome in a patient with systemic sclerosis. (2008) (9)
- VANCOMYCIN-RESISTANT ENTEROCOCCI AND METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS : THE GRAM-POSITIVE CHALLENGES (1996) (8)
- Tobacco differentially affects the clinical-biological phenotypes of ANCA-associated vasculitides. (2015) (8)
- Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise program (SPIN-HAND): Study protocol (2018) (8)
- Antisignal recognition particle antibodies-related cardiomyopathy. (2013) (8)
- Corrigendum to “Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named churg–strauss syndrome)” [Journal of Autoimmunity 48–49 (2014) 99–103] (2014) (8)
- Computed Tomography Findings Of Pulmonary Veno-Occlusive Disease In Scleroderma Patients Presenting With Precapillary Pulmonary Hypertension (2012) (8)
- Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function. (2017) (8)
- Serum 1,25(OH)2 Vitamin D and 25(OH) Vitamin D Ratio for the Diagnosis of Sarcoidosis-Related Uveitis (2018) (8)
- Treatment of Syphilis-Associated Cerebral Vasculitis: Reappearance of an Old Question. (2018) (8)
- [Infectious complications of systemic sclerosis]. (2009) (8)
- [Pathogenesis of primary systemic vasculitides (II): ANCA-negative vasculitides]. (2005) (8)
- Physical or Occupational Therapy Use in Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network Cohort Study (2019) (8)
- Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients (2020) (8)
- Immunogenicity of BNT162b2 vaccine Against the Alpha and Delta Variants in Immunocompromised Patients (2021) (8)
- Survival Improved in Patients Aged ≤ 70 Years With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension During the Period 2006 to 2017 in France (2020) (8)
- Carotid artery intima–media thickness, heat shock proteins and oxidized LDL autoantibodies in systemic necrotizing vasculitis (2008) (7)
- Efficacy of baricitinib for refractory large vessel vasculitis. (2021) (7)
- Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group Registry (2022) (7)
- The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility Trial (2019) (7)
- Ocular safety profile of BRAF and MEK inhibitors: data from the World Health Organization Pharmacovigilance Database. (2021) (7)
- Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysis. (2020) (7)
- Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study (2020) (7)
- Morphoea (localized scleroderma): baseline body surface involvement and antinuclear antibody may have a prognostic value (2009) (7)
- Role of B-Cell in the Pathogenesis of Systemic Sclerosis (2022) (7)
- Pathophysiology of systemic sclerosis. (2021) (7)
- Construction of an ICF core set and ICF-based questionnaire assessing activities and participation in patients with systemic sclerosis. (2019) (7)
- Systemic scleroderma associated with bilateral ulnar nerve entrapment at the elbow. (2000) (7)
- Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17‐item Scleroderma Functional scale (2020) (7)
- Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss). (2021) (7)
- [Pathogenesis of primary systemic vasculitides (I): ANCA-positive vasculitides]. (2005) (7)
- Myeloproliferative neoplasms and clonal hematopoiesis in patients with giant cell arteritis: a case-control and exploratory study. (2021) (7)
- Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA), polyarteritis nodosa (PAN) and microscopic polyangiitis (MPA) with no initial Five-Factor Score-defined poor-prognosis factors (FFS = 0): Baseline factors associated with cytotoxic agent and immunomodulator prescription (2013) (6)
- Analysis of self-reactive antibody repertoires in normal pregnancy. (1998) (6)
- Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort study (2022) (6)
- [Dyspnea upon exertion in systemic scleroderma: from symptom to etiological diagnosis]. (2009) (6)
- Lymphocyte Immunophenotyping and CD4/CD8 Ratio in Cerebrospinal Fluid for the Diagnosis of Sarcoidosis-related Uveitis (2019) (6)
- An immunohistochemical analysis of fibroblasts in giant cell arteritis. (2021) (6)
- Vascularites pulmonaires: le point de vue du pathologiste. (2000) (6)
- [Treatment of severe Behçet's disease with anti-TNF-alpha: infliximab. A case report]. (2002) (6)
- Selective impairment of serum antibody repertoires toward muscle and thymus antigens in patients with seropositive and seronegative myasthenia gravis (1997) (6)
- [Psychiatric manifestations of systemic sclerosis]. (2002) (6)
- [Antileukotrienes and Churg-Strauss syndrome]. (2007) (6)
- Barriers and Facilitators to Physical Activity for People With Scleroderma: A Scleroderma Patient‐Centered Intervention Network Cohort Study (2021) (6)
- [Intravenous immunoglobulins in autoimmune and inflammatory disorders: beyond a simple substitution]. (2009) (6)
- Immunizations in Adult Patients with Systemic Sclerosis (2009) (6)
- Skin necrosis revealing antiphospholipid syndrome during immunotherapy for melanoma. (2010) (6)
- Telangiectasic mastocytosis with systemic sclerosis. (2013) (6)
- Interferon-alpha in corticosteroid-resistant asthma and Churg-Strauss syndrome. (2003) (6)
- [Therapeutic management of systemic sclerosis]. (2006) (6)
- A French cohort of patients with giant cell arteritis: glucocorticoid treatment and its associated side effects. (2021) (6)
- Recurrent acute pericarditis in Takayasu arteritis. (2013) (5)
- A role for IL-33–activated ILC2s in eosinophilic vasculitis (2021) (5)
- Ethnic influence on the phenotype of French patients with systemic sclerosis. (2020) (5)
- Aortic thrombosis in young women with Crohn's disease receiving adalimumab: report of two cases. (2011) (5)
- Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse events. (2020) (5)
- Skewed peripheral B- and T-cell compartments in patients with ANCA-associated vasculitis. (2020) (5)
- [Anti-TNFalpha therapy in systemic autoimmune and/or inflammatory diseases]. (2009) (5)
- [Immunomodulatory effects of intravenous immunoglobulins in autoimmune diseases]. (1999) (5)
- Rituximab as first‐line therapy for acquired haemophilia A: a single‐centre 10‐year experience (2016) (5)
- Favorable outcome of gemcitabine-induced respiratory distress syndrome. (2000) (5)
- Proteomic Analysis of Human Scleroderma Fibroblasts Response to Transforming Growth Factor‐ß (2018) (5)
- Workload, well-being and career satisfaction among French internal medicine physicians and residents in 2018 (2019) (5)
- [Pathophysiology of ANCA-associated vasculitides]. (2012) (5)
- [Periarteritis nodosa induced by hepatitis B virus]. (1999) (5)
- [Causes and mechanisms of systemic vasculitides]. (2008) (5)
- [Digital ulcers in systemic scleroderma]. (2011) (5)
- [Management of digital ulcers from systemic scleroderma]. (2008) (5)
- [Idiopathic retroperitoneal fibrosis: a multicentric retrospective study of 30 French cases and follow-up of the renal function]. (2014) (5)
- Efficacy and safety of treatments in cutaneous polyarteritis nodosa: a French observational retrospective study. (2021) (5)
- Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis (2022) (5)
- The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET. (2022) (5)
- Survival improved in systemic sclerosis associated pulmonary arterial hypertension patients aged 70 years or less over the period 2006-2017 in France. (2019) (5)
- [Valvular locations in Whipple's disease: report of two cases and review of the literature]. (2001) (4)
- Drug-induced eosinophilic fasciitis: a dual pharmacovigilance analysis. (2021) (4)
- Autoantibodies versus Skin Fibrosis Extent in Systemic Sclerosis: A Case-Control Study of Inverted Phenotypes (2022) (4)
- Sustained Remission of Granulomatosis With Polyangiitis After Discontinuation of Glucocorticoids and Immunosuppressant Therapy: Data From the French Vasculitis Study Group Registry (2021) (4)
- Quality of Life in Systemic Sclerosis (2010) (4)
- Altered salivary redox homeostasis in patients with systemic sclerosis (2006) (4)
- Localised Versus Systemic Granulomatosis with Polyangiitis: Data from the French Vasculitis Study Group Registry. (2021) (4)
- Development and validation of a patient‐reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale * (2021) (4)
- A Mimic of p21 WAF1/CIP1 Ameliorates Murine Lupus 1 (2005) (4)
- [Relapsing polychondritis: What's new in 2017?] (2018) (4)
- Iconography : Bosentan for treatment of active digital ulcers in patients with systemic sclerosis (9 cases) (2008) (4)
- [Investigation of the complement system in clinical practice]. (2003) (4)
- Epidemiology, Environmental, and Infectious Risk Factors (2017) (4)
- [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies]. (2009) (4)
- Mental health before and during the pandemic in people with systemic sclerosis (2021) (4)
- Presentation, Diagnosis and Management of Subglottic and Tracheal Stenosis During Systemic Inflammatory Diseases. (2021) (4)
- [Neuropsychiatric manifestations in systemic sclerosis]. (2010) (4)
- Risk of malignancy in patients treated for systemic necrotising vasculitis (2019) (4)
- Risk of infection in systemic diseases. (2009) (4)
- A Mimic of p21 Ameliorates Murine Lupus (2005) (4)
- Costs of intravenous immunoglobulin therapy in patients with unconfirmed parvovirus b19 pure red cell aplasia. (2015) (4)
- [Tuberculosis risk among patients with systemic diseases]. (2009) (4)
- [Treatment of ANCA-positive systemic vasculitis with intravenous immunoglobins]. (1999) (4)
- Atypical vasculitis mimicking chronic thromboembolic pulmonary hypertension. (2015) (4)
- Vasculitis associated with familial Mediterranean fever: a study on 16 french adult cases (2015) (4)
- Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic Sclerosis (2021) (4)
- 015 Anti-IgE monoclonal antibody (omalizumab) in refractory and relapsing eosinophilic granulomatosis with polyangiitis: data from 17 patients (2016) (4)
- [2016 review on catastrophic antiphospholipid syndrome]. (2016) (3)
- Treatment of Giant Cell Arteritis (GCA) (2022) (3)
- The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial (2021) (3)
- FRI0245 Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the french registry (2011) (3)
- Aortic angiosarcoma masquerading as inflammatory aortitis. (2019) (3)
- 264. OCULAR INVOLVEMENT IN GRANULOMATOSIS WITH POLYANGIITIS: A SINGLE-CENTER COHORT STUDY ON 63 PATIENTS (2019) (3)
- Treatment of systemic sclerosis. (2021) (3)
- [Intravenous immunoglobulins: anti-infection indications]. (2000) (3)
- Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? (2013) (3)
- [Immunomodulatory effects of intravenous immunoglobulins]. (2004) (3)
- Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program (2022) (3)
- [Intravenous immunoglobulins: therapeutic indications]. (2005) (3)
- [Immunoglobulins and physiopathology: actual indications]. (2007) (3)
- [Professional consequences of systemic sclerosis]. (2013) (3)
- [Pathophysiology of eosinophilic granulomatosis with polyangitis (Churg-Strauss)]. (2016) (3)
- Indications for biotherapy in systemic vasculitides (2007) (3)
- [Late onset of primary immune deficiencies]. (2010) (3)
- Autoantibodies in Therapeutic Preparations of Human IgG (IVIg) (1996) (3)
- Effects of non-pharmacological and non-surgical interventions on health outcomes in systemic sclerosis: protocol for a living systematic review (2021) (3)
- IgA monoclonal gammopathy associated with refractory IgA vasculitis successfully treated with clone-targeted therapy. (2020) (3)
- Inflammation, Growth Factors, and Pulmonary Vascular Remodeling (2016) (3)
- [Systemic sclerosis: from physiopathology to treatment]. (2007) (3)
- Free prednisolone pharmacokinetics predicted from total concentrations in patients with inflammatory – immunonologic conditions (2020) (3)
- [Physiopathology of giant cell arteritis: From inflammation to vascular remodeling]. (2019) (3)
- Ophthalmic involvement of chronic lymphocytic leukemia: a systematic review of 123 cases. (2020) (3)
- Association study of CRP gene in systemic sclerosis in European Caucasian population (2014) (3)
- Giardia lamblia infection in a patient with myotonic dystrophy. (2002) (3)
- High D-dimer plasma concentration in systemic sclerosis patients: Prevalence and association with vascular complications (2020) (3)
- Factors associated with patient-reported likelihood of using online self-care interventions: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study (2019) (3)
- Whole blood gene expression profiling distinguishes systemic sclerosis‐overlap syndromes from other subsets (2020) (3)
- Pain levels and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a multicentre cross-sectional study (2021) (3)
- THU0237 Impact of recurrent ischemic digital ulcers on hand disability in systemic sclerosis – (2013) (2)
- [The contribution of philosophy to immunology]. (2010) (2)
- Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus: the French GR2 study (2022) (2)
- Systemic sclerosis: views and thoughts for the future. (2014) (2)
- Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis (2022) (2)
- Management of severe renal disease in anti-neutrophil-cytoplasmic-antibody-associated vasculitis: place of rituximab and plasma exchange? (2022) (2)
- [Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases]. (1993) (2)
- [Systemic sclerosis associated pulmonary arterial hypertension: the pitfalls]. (2011) (2)
- French Vasculitis Study Group recommendations for the management of COVID-19 vaccination and prophylaxis in patients with systemic vasculitis (2021) (2)
- Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis. (2022) (2)
- [Indications for intravenous immunoglobulins]. (2006) (2)
- Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort (2022) (2)
- [Sjögren's syndrome and non-Hodgkin's lymphoma: from pathophysiology to treatment]. (2011) (2)
- at proteins involved in the transforming growth factor beta pathway in patients with systemic sclerosis. (2011) (2)
- Syndrome catastrophique des antiphospholipides (CAPS) : revue 2016 (2016) (2)
- [Pulmonary arterial hypertension associated with connective tissue diseases]. (2014) (2)
- Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case report (2017) (2)
- Role of therapeutic plasma exchanges in systemic vasculitis. (2020) (2)
- Treatment of relapsing polychondritis: a systematic review. (2021) (2)
- [Therapeutic indications of intravenous immunoglobulins]. (2003) (2)
- Granulomatosis with Polyangiitis Sustained Remission Off-Therapy: Data from the French Vasculitis Study Group Registry. (2020) (2)
- LB0002 Does Adding Azathioprine To Glucocorticoid Induction Increase The Remission Rate and Prevent Relapses in Patients with Systemic Necrotizing Vasculitides without Poor-Prognosis Factors? A Multicenter, Double-Blind Randomized Controlled Trial (2016) (2)
- Breast adenocarcinoma complicating Kallmann's syndrome. (2001) (2)
- Patients of 75 years and over with ANCA‐associated vasculitis have a lower relapse risk than younger patients: A multicentre cohort study (2021) (2)
- [Biotherapies: toward a second revolution?]. (2009) (2)
- [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders]. (2007) (2)
- [Necrotizing myopathy associated with anti-SRP auto-antibodies: transient efficacy of a therapeutic strategy associating plasma exchanges and rituximab]. (2012) (2)
- A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency (2019) (2)
- Celiprolol-induced lupus-like syndrome (2006) (2)
- Abdominal adipose tissue predicts major cardiovascular events in systemic necrotising vasculitides. (2019) (2)
- How to optimize the treatment of systemic vasculitides. (2000) (2)
- Health Outcomes of 215 Mothers of Children With Autoimmune Congenital Heart Block: Analysis of the French Neonatal Lupus Syndrome Registry (2022) (2)
- [Superficial porokeratosis of the lower limbs during systemic scleroderma]. (2009) (2)
- [Severe cholestatic hepatitis revealing a DRESS syndrome]. (2013) (2)
- Physiopathologie des vascularites ANCA-positives : acquisitions récentes (2003) (2)
- Long-term outcomes of the WEGENT trial on remission-maintenance for granulomatosis with polyangiitis or microscopic polyangiitis (2019) (2)
- OP0123 Prediction of progressive skin thickening in early diffuse systemic sclerosis using three-monthly skin scores from the european scleroderma observational study (ESOS) (2017) (2)
- Reply to "Anti-endothelial cell antibodies in patients with AAV: the relationship with ANCA? Comment on: Identification of target antigens of anti-endothelial cell antibodies in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides: a proteomic approach" by Shen-Ju Gou, Ping Fu. (2014) (1)
- Innate immunity and natural autoantibodies (2007) (1)
- FRI0261 Observational Study of Outcome in Patients with Early Diffuse Cutaneous Systemic Sclerosis Treated with Immunosuppressive Therapies (ESOS Study) (2016) (1)
- FRI0299 Pulmonary Arterial Hypertension in Idiopathic Inflammatory Myopathies: Data from The French Pulmonary Hypertension Registry and Review of The Literature (2016) (1)
- [Severe respiratory syncytial virus pneumonia following bone marrow autograft. 3 cases]. (1992) (1)
- 355. FACTORS PREDICTING SEVERE INFECTIONS IN PATIENTS WITH SYSTEMIC NECROTIZING VASCULITIDES BASED ON DATA FROM 733 PATIENTS ENROLLED IN RANDOMIZED–CONTROLLED TRIALS (2019) (1)
- Rare within rare. Necrotising scleritis and peripheral ulcerative keratitis: eye-threatening complications of relapsing polychondritis. (2021) (1)
- Basic (PS01–PS58) (2012) (1)
- The Clinical Spectrum and Outcome of Uveomeningitis: A Comprehensive Analysis of 110 Cases (2021) (1)
- [Mandibular resorption, an underdiagnosed manifestation of systemic scleroderma]. (2006) (1)
- [Recombinant proteins or monoclonal antibodies: comparative properties and interest in systemic lupus erythematosus]. (2013) (1)
- Chronic Obstructive Pulmonary Disease Associated with Hypocomplementemic Urticarial Vasculitis. (2020) (1)
- [Pansclerotic morphea with a rapidly fatal outcome in an 11-year-old girl]. (2016) (1)
- Corrigendum to: Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients. (2022) (1)
- Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison. (2022) (1)
- FRI0508 Analysis of risk factors of adverse obstetrical outcome in patients with takayasu arteritis (2018) (1)
- Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise program (SPIN-HAND) (2022) (1)
- [Humoral and cellular autoimmunity: from physiology to pathology]. (2009) (1)
- Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study (2022) (1)
- Characteristics of patients with systemic sclerosis suffering from a lower limb amputation: Results of a French collaborative study (2020) (1)
- Contribution of anti-ferritin antibodies to the diagnosis of giant cell arteritis (2013) (1)
- Treatment of infections caused by highly resistant enterococci. (1997) (1)
- L44. Management of relapses in vasculitis. (2013) (1)
- [Heart involvement in systemic lupus erythematosus and antiphospholipid syndrome]. (2022) (1)
- [Long-term treatments for systemic sclerosis: what are the perspectives?]. (2002) (1)
- Comparison of Mental Health Symptoms Prior to and During COVID-19 among Patients with Systemic Sclerosis from Four Countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study (2020) (1)
- [Diagnosis of primary immunodeficiency in adult patients]. (2006) (1)
- Lymphoplasmacytic lymphoma associated with polyradiculoneuritis and cryoglobulinemia mimicking polyarteritis nodosa. (2007) (1)
- AB0727 There is a Need for New Systemic Sclerosis Subset Criteria. A Content Analytic Approach (2015) (1)
- [The reform of the third cycle of medical studies: What changes for internal medicine?] (2017) (1)
- SAT0465 Construct Validity of the Promis-29 in Systemic Sclerosis: Preliminary Results from the Scleroderma Patient-Centered Intervention Network (Spin) Cohort (2015) (1)
- Cluster analysis reveals eosinophilia and fibrosis as poor prognostic markers in 128 patients with eosinophilic fasciitis. (2022) (1)
- Hypervirulent Klebsiella Pneumoniae, an Emerging Cause of Endogenous Endophthalmitis in A French Center: A Comparative Cohort Study. (2022) (1)
- Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual (2022) (1)
- Primary and secondary glomerulonephritis I (2012) (1)
- [Physiopathology of polymyositis and dermatomyositis, mechanism of action of intravenous immunoglobulins]. (2004) (1)
- Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases. (2022) (1)
- [Eosinophilic pleural effusion associated to Churg and Strauss syndrome]. (2008) (1)
- Extracorporeal photopheresis and cyclophosphamide for cancer-associated systemic sclerosis worsening induced by immune checkpoint inhibitors: a case report. (2022) (1)
- [Pathogenesis of ANCA-positive vasculitides: recent advances]. (2003) (1)
- Impact of air pollution on systemic sclerosis associated interstitial lung disease severity: a retrospective two-center cohort study (2022) (1)
- THU0312 ADVENTITIAL FIBROBLAST, AN IMPORTANT PLAYER IN GIANT CELL ARTERITIS (2019) (0)
- membrane expression of the chemokine receptor CXCR4 Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired (2013) (0)
- [Benefits and risks of treatments used in systemic autoimmune diseases]. (2008) (0)
- FRI0369 Neurotrophins are involved in vascular remodelling of giant cell arteritis. (2013) (0)
- Sarcoidose et Oeil. SFO. pdf (2016) (0)
- SP071ROLE OF COMPLEMENT IN SCLERODERMA RENAL CRISIS (2017) (0)
- THU0316 Update on the juvenile systemic sclerosis inception cohort. www.juvenilescleroderma.com (2013) (0)
- [Intravenous immunoglobulin therapy]. (2005) (0)
- Mental health symptoms in scleroderma during COVID-19: a Scleroderma Patient-centred Intervention Network (SPIN) cohort longitudinal study. (2023) (0)
- Presentation and management of granulomatosis with polyangiitis (Wegener’s) (GPA) central nervous system (CNS) involvement (2013) (0)
- AB0439 Contribution of anti-ferritin antibodies to the diagnosis of giant cell arteritis (2013) (0)
- Pregnancy and Scleroderma (2012) (0)
- [Pulmonary vasculitis: histopathologic point of view]. (2000) (0)
- Mise au point - Orientation diagnostique devant une lymphopénie (2008) (0)
- patients, to systemic dissemination and the acute onset of systemic vasculitis progressive immune complex formation and deposition. (2001) (0)
- Randomized controlled trial of an internet-based self-guided hand exercise program to improve hand function in people with systemic sclerosis: the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND) trial (2022) (0)
- Clinico-radiological correlation and prognostic value of baseline chest computed tomography in eosinophilic granulomatosis with polyangiitis. (2023) (0)
- Dr. Pène, et al reply (2016) (0)
- Patient Acceptable Symptom State for Burden From Appearance Changes in People With Systemic Sclerosis: A Cross-sectional Survey (2022) (0)
- OP0058 Efficacy of Sildenafil on Ischaemic Digital Ulcer Healing in Systemic Sclerosis: The Placebo-Controlled Seduce Study (2015) (0)
- SAT0270 COMPREHENSIVE ICF CORE SET AND ICF-BASED QUESTIONNAIRE ASSESSING ACTIVITIES AND PARTICIPATION IN PATIENTS WITH SYSTEMIC SCLEROSIS: THE SCISCIF STUDY (2019) (0)
- 013 WHO surgical checklist in dermatology: compliance, attitudes, barriers (2016) (0)
- A method of diagnosing systemic scleroderma or pulmonary hypertension (2009) (0)
- Systemic Sclerosis : Results from 2 Large European Caucasian Cohorts Autoimmune Risk Loci in CD 58 and ITGAM , ITGAX , Association Study of YANNICK ALLANORE (2011) (0)
- [Hand: a tool for the diagnosis and evaluation of consequences of diseases]. (2013) (0)
- Physical and Occupational Therapy (2012) (0)
- [Pregnancy in systemic sclerosis]. (2008) (0)
- [Late-onset asthma in a traveler]. (2011) (0)
- Patient acceptable symptom state and minimally clinically important difference for patient-reported outcomes in systemic sclerosis: A secondary analysis of the sclereduc trial (2018) (0)
- Validity, Reliability, and Differential Item Functioning of English and French Versions of the 10-Item Connor-Davidson Resilience Scale in Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study. (2023) (0)
- Promotes Inflammation Impairs Macrophage Phagocytosis, and with Calreticulin on Apoptotic Neutrophils, Granulomatosis with Polyangiitis, Associates Proteinase 3, the Autoantigen in (2012) (0)
- Mental Health Care Use and Associated Factors in Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study (2022) (0)
- [Reliability and validity of a workbook for assessment of professional competencies of internal medicine residents]. (2019) (0)
- Title: Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Short title: Exhaled CANO and scleroderma lung disease (2007) (0)
- Digital Ischemia Induced by Fesoterodine. (2018) (0)
- autoimmune encephalomyelitis immunoglobulin: a critical factor in controlling experimental Expansion of CD4+CD25+ regulatory T cells by intravenous (2013) (0)
- [Pulmonary manifestations associated with immunosuppressive treatments used in transplantation and autoimmune diseases]. (2010) (0)
- Differentiating tracheobronchial involvement in granulomatosis with polyangiitis and relapsing polychondritis on chest CT: a cohort study (2022) (0)
- Differences in Disability Perception in Systemic Sclerosis: A Mirror Survey of Patients and Health Care Providers (2023) (0)
- Systemic sclerosis (2017) (0)
- OP0090 Determinants of Survival of Fetuses with Autoimmune Congenital Heart Block and Factors Associated with Neonatal and Late-Onset Dilated Cardiomyopathy: 214 Cases from the French Registry of Neonatal Lupus (2015) (0)
- Computerized interstitial fibrosis quantification is the most powerful histological predictor of renal outcome in ANCA-associated vasculitis (2013) (0)
- S.11.1 Influence of digital ulcer healing on disability and daily activity limitations in SSc (2012) (0)
- Scleroderma renal crisis triggered by ibuprofen: Insights on complement-directed therapy (2023) (0)
- Arthrose : quels enjeux en 2010 ? (2010) (0)
- FRI0253 Use of bosentan for the prevention of digital ulcers related to systemic sclerosis. Retrospective french study of 89 patients treated since 2007 (2013) (0)
- O29 Determination of homogenous subgroups of antiphospholipid syndrome: cluster analysis based on 509 cases (2020) (0)
- Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysis. (2020) (0)
- Frequency and impact on prognosis of signs of pulmonary veno-occlusive disease on high resolution computed tomography in patients with scleroderma associated pulmonary arterial hypertension (2011) (0)
- SAT0649 DEVELOPMENT AND VALIDATION OF A PATIENT-REPORTED OUTCOME ASSESSING ACTIVITY LIMITATION AND PARTICIPATION RESTRICTION OF PATIENTS WITH SYSTEMIC SCLEROSIS: THE COCHIN 17-ITEM SCLERODERMA FUNCTIONAL SCALE (CSF-17) (2019) (0)
- Angioimmunoblastic T-cell lymphoma mimicking eosinophilic granulomatosis with polyangiitis (Churg-Strauss). (2018) (0)
- SP0196 Delivering an Online Disease-Specific Rehabilitation Intervention: Examples from the SPIN Hand Project (2014) (0)
- Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET (2022) (0)
- Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients. (2023) (0)
- SAT0239 PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG–STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS (2019) (0)
- Evaluation of Measurement Properties and Differential Item Functioning in English and French Versions of the UCLA Loneliness Scale-6: A Scleroderma Patient-Centered Intervention Network (SPIN) Study. (2023) (0)
- THU0427 New Insights into the Presentation and the Management of Hepatitis B Reactivation in Patients with Immune Mediated Inflammatory Diseases (2013) (0)
- Comprehensive icf core set and icf core set-derived activities and participation questionnaire for patients with systemic sclerosis: Results of the SCISCIF study (2018) (0)
- OP0096 Relevance of the 6-Minute Walking Test in Assessing the Severity of Pulmonary Arterial Hypertension Associated with Systemic Sclerosis, without Interstitial Lung Disease (2014) (0)
- Proteinase 3 (PR3) is a phosphatidylserine-binding protein that can bind microparticles: Relevance in the context of granulomatosis with polyangiitis (GPA) (2013) (0)
- Factors associated with major cardiovascular events in patients with primary systemic necrotizing vasculitides: Results of a longitudinal long-term follow-up study (2013) (0)
- [Common variable immunodeficiency: one or multiple illnesses? 3 clinical cases]. (1999) (0)
- SAT0226 MINOR SALIVARY GLAND BIOPSY TO DIAGNOSE LYMPHOMA IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (2020) (0)
- AB0620 High risk of mistaken classification of primary antiphospholipid syndrome as systemic lupus erythematosusaccording to the slicc criteria: analysis of a cohort of 214 antiphospholipid patients (2018) (0)
- POS0317 THE PERFORMANCE OF DIFFUSING CAPACITY FOR MONOXIDE CARBON (DLCO) AND FORCED VITAL CAPACITY (FVC) IN PREDICTING THE ONSET OF SYSTEMIC SCLEROSIS (SSc)-INTERSTITIAL LUNG DISEASE (ILD) IN THE EUROPEAN SCLERODERMA TRIALS AND RESEARCH (EUSTAR) DATABASE (2021) (0)
- SAT0351 Tocilizumab in Giant Cell Arteritis: A Multicentre Open-Label Study OF34 Patients (2016) (0)
- THU0275 SEVERE PREECLAMPSIA RELATED TO ANTIPHOSPHOLIPID SYNDROME: AN EUROPEAN STUDY OF 40 WOMEN (2020) (0)
- Reply to the comment of Fayet et al. Obstacles and motivations to influenza and pneumococcal vaccination in patients with rheumatoid arthritis. A qualitative study. (2019) (0)
- AB0467 REMISSION AND LOW DISEASE ACTIVITY STATE IN PATIENTS WITH GRANULOMATOSIS WITH POLYANGIITIS AND MICROSCOPIC POLYANGIITIS: PREVALENCE AND IMPACT ON DAMAGE ACCRUAL (2020) (0)
- Association cancer et syndrome des antisynthétases (2011) (0)
- Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients. (2022) (0)
- Exploring research team members' and trial participants' perceptions of acceptability and implementation within one videoconference-based supportive care program for individuals affected by systemic sclerosis during COVID-19: a qualitative interview study. (2023) (0)
- A qualitative interview study exploring the psychological health impacts of the SPIN-CHAT program among people with systemic sclerosis at the onset of COVID-19: perceptions of trial participants and research team members. (2023) (0)
- Chapter-04 Neutrophils in ANCA-associated Vasculitis (2015) (0)
- [Risk of infection and systemic inflammatory and/or autoimmune diseases: where do we stand in 2009?]. (2009) (0)
- Detection of Antibodies to Tenascin-C in Patients with Idiopathic Pulmonary Arterial Hypertension. (2009) (0)
- Lymphopénie CD4 idiopathique : suivi à long terme d’une cohorte de 36 patients (2012) (0)
- Tumor Necrosis Factor-α Blockade and the Risk of Vasculitis (2004) (0)
- New Insights into the Pathogenesis of Giant Cell Arteritis through a Genome-Wide Association Study (2016) (0)
- Primary biliary cholangitis and systemic sclerosis (Reynolds syndrome): A case–control study (2021) (0)
- Increased migration and proliferation potential characterized vascular smooth muscle cells from patients with giant cell arteritis (2013) (0)
- [Treatment of scleroderma]. (2002) (0)
- ORIGINAL ARTICLE Antibodies to fibroblasts in idiopathic and scleroderma associated pulmonary hypertension (2006) (0)
- In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicenter study. (2023) (0)
- AB0199 ASSESSING DISABILITY AND QUALITY OF LIFE IN ALGERIAN SYSTEMIC SCLEROSIS PATIENTS: CONSTRUCT VALIDITIES OF THE ARAB HAND FUNCTION INDEX AND HEALTH ASSESSMENT QUESTIONNAIRE (HAQ) (2019) (0)
- [Osteoarthritis: what are the challenges in 2010?]. (2010) (0)
- Don't mix apples and oranges. Reply to Azoulay et al. (2022) (0)
- 12. New Registries (2018) (0)
- Distal Lung Inflammation Assessed by Alveolar Concentration of Nitric Oxide Is an Individualised Biomarker of Severe COVID-19 Pneumonia (2022) (0)
- After three years of health crisis, it is time to (finally) support general internal medicine! (2022) (0)
- [Immunity, autoimmunity, aging]. (2008) (0)
- Pulmonary Perspective Systemic Sclerosis-associated Pulmonary Arterial Hypertension (2010) (0)
- Rapidly progressive glomerulonephritis is not the sole presentation of renal involvement in ANCA associated vasculitis (2013) (0)
- SAT0323 Improvement of Digital Ulcerative Disease in Patients with Systemic Sclerosis is Associated with Better Functional Prognosis (2014) (0)
- GENETIC DIAGNOSIS GUIDES TREATMENT OF AUTOIMMUNE ENTEROPATHY. (2022) (0)
- [Autoantibodies in clinical practice]. (2006) (0)
- Auteurs et Collaborateurs (2013) (0)
- Evaluation of bladder-sphincter disorders sclerodermia: 69 patients (2011) (0)
- Abstract 4383: Incidence of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis: A 3-Year Longitudinal Study (2008) (0)
- Pulmonary arterial hypertension in idiopathic in fl ammatory myopathies Data from the French pulmonary hypertension registry and review of the literature (2016) (0)
- method of diagnosing a pulmonary arterial hypertension. (2008) (0)
- Osteitis in Systemic Sclerosis: A Nationwide Case–Control Retrospective Study (2020) (0)
- Title The Scleroderma Patient-centered Intervention Network ( SPIN ) Cohort : Protocol for a cohort multiple randomised controlled trial ( cmRCT ) design to support trials of psychosocial and rehabilitation interventions in a rare disease context Permalink (2013) (0)
- Anti-Vascular Smooth Muscle Cell Antibodies in the Serum of Patients with Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Bind to Cytoskeleton, Oxidative Stress and Cell Cycle Antigens. (2009) (0)
- [What's new in internal medicine?]. (2015) (0)
- [Chronic obstructive pulmonary disease: an autoimmune disease?]. (2012) (0)
- [Interstitial lung disease in systemic sclerosis]. (2006) (0)
- [Lymphocytic meningitis in a 70-year-old woman]. (2016) (0)
- Clinical Impact of Digital Ulcers (2018) (0)
- Sexual disorders in 83 patients with systemic sclerosis (2011) (0)
- 117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS (2019) (0)
- Score to assess the probability of relapse in granulomatosis with polyangiitis and microscopic polyangiitis (2023) (0)
- Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis. (2023) (0)
- [Primary immune deficiencies: also found in adults. A diagnosis to be aware of]. (2006) (0)
- PROTEINURIA AND HEMATURIA AFTER REMISSION INDUCTION ARE ASSOCIATED WITH OUTCOME IN ANCA-ASSOCIATED VASCULITIS. (2023) (0)
- [Pulmonary involvement in systemic scleroderma]. (2011) (0)
- Pneumopathies infiltrantes diffuses des connectivites (2005) (0)
- Secondary vasculitis P 197 Thrombotic vasculopathy with neovascularisation associated with probably levamisole-contaminated cocaine : Report of 2 cases (2013) (0)
- Tracheal and bronchial stenoses in granulomatosis with polyangiitis (Wegener) (GPA) (2013) (0)
- [Intraparenchymal hemorrhage disclosing a primary angiitis of the central nervous system]. (2009) (0)
- 056. CHARACTERISTICS BY AUTOANTIBODY STATUS IN PATIENTS WITH EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS: THE EUROPEAN SCLERODERMA OBSERVATIONAL STUDY COHORT (2017) (0)
- 354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS (2019) (0)
- Therapeutical indications of the intravenous immunoglobulin (except in autoimmune thrombopenic purpura) (2005) (0)
- [Flu vaccine and auto-immune and/or inflammatory diseases]. (2011) (0)
- Microangiopathie thrombotique compliquant un syndrome POEMS : cas clinique (2001) (0)
- Survival and prognosis factors in systemic sclerosis: Data of a French multicenter cohort of incident patients, systematic review and meta-analysis of the literature (2017) (0)
- FRI0343 Factors associated with major cardiovascular events in patients with primary systemic necrotizing vasculitides: results of a longitudinal long-term follow-up study (2013) (0)
- FRI0287 EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS (2019) (0)
- Rituximab plus methotrexate combination as a salvage therapy in persistently active granulomatosis with polyangiitis. (2021) (0)
- AB0984 Development of a Juvenile Systemic Sclerosis Response Index (JSSRI) (2015) (0)
- Épidémiologie, classification des connectivites (2018) (0)
- [Immunomodulator effects of intravenous immunoglobulins in neurological autoimmune diseases]. (1995) (0)
- PReS-FINAL-2284: SLE and complement deficiencies: a French multicentric retrospective study (2013) (0)
- POS0323 ANTI PM-SCL ASSOCIATED AUTO IMMUNE DISEASES: MULTICENTRIC COHORT OF 128 PATIENTS (2021) (0)
- Thrombopoietin-dependent Myelo-megakaryopoiesis Fuels Thromboinflammation and Worsens Antibody-mediated Chronic Renal Microvascular Injury. (2023) (0)
- OP0030 GRANULOMATOSIS WITH POLYANGIITIS SUSTAINED REMISSION OFF-THERAPY: DATA FROM THE FRENCH VASCULITIS STUDY GROUP REGISTRY (2020) (0)
- AB0787 Influence of digital ulcer healing on disability and daily activity limitations in systemic sclerosis (2013) (0)
- Fabry disease - from diagnosis to treatment: analysis of 19 families in France and Switzerland (2005) (0)
- [Inventory of training of internal medicine in France: Results of a national survey]. (2017) (0)
- Acquired C1-Inhibitor Deficiency: 7 Patients Treated with Rituximab (2012) (0)
- Autoimmune systemic diseases (2012) (0)
- [Diagnosis of primary immune deficiencies in adults]. (2005) (0)
- Identification of target antigens of anti-endothelial cell antibodies in patients with ANCA-associated systemic vasculitis: A proteomic approach (2013) (0)
- immunoglobulin Inhibition of maturation and function of dendritic cells by intravenous (2013) (0)
- Identification of an expression-based set of genes to predict the subset of patients with systemic scleroderma (SSc) (2016) (0)
- Successful outcome under multiple therapy in two cases of anti-MDA5 dermatomyositis with severe cardiomyopathy and interstitial lung disease. (2023) (0)
- Systemic sclerosis associated myopathy. (2022) (0)
- Additional file 3: of Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis (2016) (0)
- 12 Pregnancy and Scleroderma (0)
- [Management of patients with a suspicion of giant cell arteritis: Survey among general practitioners and specialists]. (2021) (0)
- Potential defect in annexin-A1-dependent anti-inflammatory mechanisms in GPA: Its cleavage by PR3 and its inhibition by autoantibodies (2013) (0)
- FRI0342 Identification of target antigens of anti-endothelial cell antibodies in patients with anca-associated systemic vasculitis: a proteomic approach (2013) (0)
- Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease. (2022) (0)
- Evaluation of the severe preeclampsia classification criterion for antiphospholipid syndrome in a study of 40 patients (2021) (0)
- Anti-PM-Scl antibodies positive patients encompass three different groups with distinct prognosis. (2022) (0)
- The Advantage of Specific Intravenous Immunoglobulin (sIVIG) on Regular IVIG: Experience of the Last Decade (2012) (0)
- AB0453 Presentation and management of granulomatosis with polyangiitis (wegener’s) (gpa) central nervous system (cns) involvement (2013) (0)
- Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies (2022) (0)
- Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group. (2020) (0)
- Mycophenolic acid drug monitoring in patients with systemic sclerosis associated with diffuse skin and/or pulmonary involvement: A monocentric and retrospective French study (2020) (0)
- Additional file 4: of Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis (2016) (0)
- [New insights into the pathogenesis of ANCA-positive vasculitides]. (2007) (0)
- Identification of EPX variants in Human Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss). (2023) (0)
- [Contribution and limits of "OSCE", "long-case" and "global end-of-placement marking" as end-of-rotation assessment methods. Experience from two internal medicine wards]. (2022) (0)
- Correction to: A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency (2020) (0)
- Features of non-Hodgkin's lymphoma diagnosed in minor salivary gland biopsies from primary Sjögren's syndrome patients. (2021) (0)
- [Atherosclerosis: an immunologic disease?]. (2006) (0)
- Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography : a prospective study on 20 patients (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Luc Mouthon?
Luc Mouthon is affiliated with the following schools: